Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Premenstrual dysphoric disorder: a review for the treating practitioner Kaur G; Gonsalves L; Thacker HLCleve Clin J Med 2004[Apr]; 71 (4): 303-5, 312-3, 317-8 passimPremenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome (PMS), is characterized by physical and behavioral symptoms that cause marked social impairment during the last half of the menstrual cycle. Symptoms are believed to result from the interaction of central neurotransmitters and normal menstrual hormonal changes. Treatment usually begins with lifestyle changes, over-the-counter medications, and if needed, selective serotonin reuptake inhibitors. Physicians should be aware of the risks of many of the alternative therapies commonly touted in the popular press.|Adult[MESH]|Antidepressive Agents/therapeutic use[MESH]|Combined Modality Therapy[MESH]|Dietary Supplements[MESH]|Female[MESH]|Gynecology/methods[MESH]|Humans[MESH]|Ovariectomy/methods[MESH]|Phytotherapy/methods[MESH]|Premenstrual Syndrome/*diagnosis/epidemiology/*therapy[MESH]|Prognosis[MESH]|Risk Assessment[MESH]|Selective Serotonin Reuptake Inhibitors/therapeutic use[MESH]|Severity of Illness Index[MESH]|Treatment Outcome[MESH] |
